Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium

DRUG2 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 1

Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients

CompletedNCT02975843

Chiesi Farmaceutici S.p.A.Asthma, Chronic Obstructive Pulmonary Disease

Start: 2016-11-21End: 2017-04-11Updated: 2017-06-23

Phase 3

Functional Respiratory Imaging Study (FRI)

CompletedNCT03268226

Chiesi Farmaceutici S.p.A.Chronic Obstructive Pulmonary Disease

Start: 2017-11-20End: 2019-01-30Updated: 2020-03-04